Boeing Co. Stock Slides 6.9%, Underperforms Peers
Dow Jones2026/09/28 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Boeing Co. slid 6.9% to $184.39 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.8% to 7,683.69 and Dow Jones Industrial Average falling 0.7% to 51,481.51.
Boeing Co. closed 27.5% below its 52-week high of $254.35, which the company achieved on January 27th.
The stock underperformed when compared to some of its peers, as RTX Corp. fell 0.9% to $187.66, TransDigm Group Inc. fell 0.6% to $1,109.22, and Textron Inc. rose 1.02% to $77.37.
Trading volume totaled 17.8 million, compared to the 50-day average of 6.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 28, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Uncertainty clouds the US stock IPO market as smart ring manufacturer Oura (OURA.US) joins the ranks of delayed listings
Oura (OURA.US) has become the latest company to postpone its initial public offering (IPO) in the United States due to market uncertainty.
Iovance Biotherapeutics Raises 2026 Revenue Guidance
AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation
Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.
Crypto prices
More
